Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Involvement of complement in atopic dermatitis.

A Kapp, E Schöpf

    Acta Dermato-Venereologica. Supplementum
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

    Allergy·2026
    Same author

    A rare case of neuro- and otosyphilis in secondary syphilis.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Langerhans cell histiocytosis mimicking prurigo nodularis.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    Neurological disorders are associated with bullous pemphigoid.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    [Gender aspects in angioedema].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2019
    Same author

    Position statement: topical calcineurin inhibitors in atopic dermatitis.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2018
    Same journal

    Atopic eczema - new insights in the definition, diagnostics and disease management. Proceedings of a LEO eczema workshop. November 2003. Copenhagen, Denmark.

    Acta dermato-venereologica. Supplementum·2006
    Same journal

    Atopic hand eczema and treatment strategies.

    Acta dermato-venereologica. Supplementum·2005
    Same journal

    Epidemiology and job-related problems for the eczema patient.

    Acta dermato-venereologica. Supplementum·2005
    Same journal

    Treatment strategies and compliance for the adult patient with atopic eczema.

    Acta dermato-venereologica. Supplementum·2005
    Same journal

    Compliance among patients with atopic eczema.

    Acta dermato-venereologica. Supplementum·2005
    Same journal

    Contact allergic reactions in patients with atopic eczema.

    Acta dermato-venereologica. Supplementum·2005
    See all related articles

    This study found elevated complement components in patients with atopic dermatitis (AD), suggesting the complement system plays a role in AD inflammation. Further research is needed to understand C3a levels in AD.

    Area of Science:

    • Immunology
    • Dermatology
    • Complement System

    Background:

    • Atopic dermatitis (AD) is a common inflammatory skin condition.
    • The role of the complement system in AD pathogenesis is not well understood.
    • Limited data exists on complement component levels in patients with mild to intermediate AD.

    Purpose of the Study:

    • To investigate complement component and activation product levels in the peripheral blood of patients with mild to intermediate atopic dermatitis.
    • To compare these levels with those in healthy non-atopic individuals.
    • To explore potential correlations between complement levels and disease activity.

    Main Methods:

    • Study included 35 patients with mild to intermediate AD not on systemic or topical steroids for 6 weeks.

    Related Experiment Videos

  • Serum levels of complement components C3, C4, and C1 inhibitor (C1 INA) were measured using radioimmunodiffusion.
  • Plasma levels of complement activation products C3a and C5a were quantified via radioimmunoassay.

    • Main Results:

    • Significantly increased levels of C3, C4, and C1 INA were observed in AD patients compared to healthy controls.
    • A trend towards elevated C3a levels was noted, though not statistically significant.
    • No measurable C5a levels were detected in either group.
    • Elevated C3a levels showed a positive correlation with increased C3 levels.

    Conclusions:

    • The complement system appears to be involved in the inflammatory processes of atopic dermatitis.
    • Elevated levels of normal complement components suggest activation or altered regulation in AD.
    • Further investigation into the specific role of complement activation products like C3a in AD is warranted.